Conduit Pharmaceuticals Inc. (CDT)
NASDAQ: CDT · Real-Time Price · USD
1.150
-0.040 (-3.36%)
At close: Feb 21, 2025, 4:00 PM
1.230
+0.080 (6.96%)
After-hours: Feb 21, 2025, 7:59 PM EST
Conduit Pharmaceuticals Employees
Conduit Pharmaceuticals had 7 employees as of December 31, 2023.
Employees
7
Change
n/a
Growth
n/a
Revenue / Employee
n/a
Profits / Employee
-$2,164,429
Market Cap
1.38M
Employees Chart
Employees History
| Date | Employees | Change | Growth |
|---|---|---|---|
| Dec 31, 2023 | 7 | - | - |
Related Stocks
| Company Name | Employees |
|---|---|
| UnitedHealth Group | 440,000 |
| Johnson & Johnson | 131,900 |
| Thermo Fisher Scientific | 125,000 |
| Abbott Laboratories | 114,000 |
| AstraZeneca | 92,900 |
| Novo Nordisk | 77,349 |
| Novartis AG | 75,883 |
| Merck & Co. | 72,000 |
CDT News
- 2 days ago - Conduit Progresses Phase II of its AI Initiative with Sarborg - GlobeNewsWire
- 9 days ago - Conduit Pharmaceuticals Partners with Charles River in Clinically Relevant Systemic Lupus Erythematosus Model - GlobeNewsWire
- 11 days ago - Conduit Pharmaceuticals Announces Debt Repayment and Partial Conversion of Senior Secured Note - GlobeNewsWire
- 15 days ago - Conduit Pharmaceuticals Transitions to Phase II of Sarborg Collaboration to Support AI-Driven Drug Development - GlobeNewsWire
- 25 days ago - Conduit Pharmaceuticals Completes Strategic Review with Sarborg to Map Revolutionizing Drug Development with Artificial Intelligence - GlobeNewsWire
- 4 weeks ago - Conduit Pharmaceuticals Inc. Announces Reverse Stock Split - GlobeNewsWire
- 2 months ago - Conduit Pharmaceuticals to Revolutionize Drug Development Through Agreement to Use Artificial Intelligence and Cybernetics - GlobeNewsWire
- 3 months ago - Conduit Pharmaceuticals Receives Further Patent Approval For Lead Asset Targeting Autoimmune Disorders - GlobeNewsWire